These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 18635471)

  • 1. Sex-specific responses to opiates: animal and human studies.
    Dahan A; Kest B; Waxman AR; Sarton E
    Anesth Analg; 2008 Jul; 107(1):83-95. PubMed ID: 18635471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissociation between sex differences in the immunological, behavioral, and physiological effects of kappa- and delta-opioids in Fischer rats.
    Elliott JC; Picker MJ; Sparrow AJ; Lysle DT
    Psychopharmacology (Berl); 2006 Mar; 185(1):66-75. PubMed ID: 16397747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous opiates and behavior: 2014.
    Bodnar RJ
    Peptides; 2016 Jan; 75():18-70. PubMed ID: 26551874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor-selective antagonism of opioid antinociception in female versus male rats.
    Craft RM; Tseng AH; McNiel DM; Furness MS; Rice KC
    Behav Pharmacol; 2001 Dec; 12(8):591-602. PubMed ID: 11856896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-nociception mediated by a κ opioid receptor agonist is blocked by a δ receptor agonist.
    Taylor AM; Roberts KW; Pradhan AA; Akbari HA; Walwyn W; Lutfy K; Carroll FI; Cahill CM; Evans CJ
    Br J Pharmacol; 2015 Jan; 172(2):691-703. PubMed ID: 24923251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of endothelin-A receptor antagonist on mu, delta and kappa opioid receptor-mediated antinociception in mice.
    Bhalla S; Zhang Z; Patterson N; Gulati A
    Eur J Pharmacol; 2010 Jun; 635(1-3):62-71. PubMed ID: 20303944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians.
    Stevens CW
    J Pharmacol Exp Ther; 1996 Feb; 276(2):440-8. PubMed ID: 8632308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
    Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
    Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex differences in opioid analgesia: clinical and experimental findings.
    Fillingim RB; Gear RW
    Eur J Pain; 2004 Oct; 8(5):413-25. PubMed ID: 15324773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dextromethorphan and ketamine potentiate the antinociceptive effects of mu- but not delta- or kappa-opioid agonists in a mouse model of acute pain.
    Baker AK; Hoffmann VL; Meert TF
    Pharmacol Biochem Behav; 2002 Dec; 74(1):73-86. PubMed ID: 12376154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of gonadal steroid hormone treatments on opioid antinociception in ovariectomized rhesus monkeys.
    Negus SS; Mello NK
    Psychopharmacology (Berl); 2002 Jan; 159(3):275-83. PubMed ID: 11862360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system.
    King MA; Bradshaw S; Chang AH; Pintar JE; Pasternak GW
    J Neurosci; 2001 Oct; 21(19):7788-92. PubMed ID: 11567069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bovine pineal gland contains delta and mu but not kappa or ORL1 opioid receptor subtypes.
    Govitrapong P; Sawlom S; Chetsawang B; Sangchot P; Ebadi M
    Proc West Pharmacol Soc; 2002; 45():32-5. PubMed ID: 12434519
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacological characterization of ATPM [(-)-3-aminothiazolo[5,4-b]-N-cyclopropylmethylmorphinan hydrochloride], a novel mixed kappa-agonist and mu-agonist/-antagonist that attenuates morphine antinociceptive tolerance and heroin self-administration behavior.
    Wang YJ; Tao YM; Li FY; Wang YH; Xu XJ; Chen J; Cao YL; Chi ZQ; Neumeyer JL; Zhang A; Liu JG
    J Pharmacol Exp Ther; 2009 Apr; 329(1):306-13. PubMed ID: 19136637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.
    Yi SP; Kong QH; Li YL; Pan CL; Yu J; Cui BQ; Wang YF; Wang GL; Zhou PL; Wang LL; Gong ZH; Su RB; Shen YH; Yu G; Chang KJ
    Acta Pharmacol Sin; 2017 Jul; 38(7):977-989. PubMed ID: 28502978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of salmon-calcitonin on the analgesic effect of selective mu, delta and kappa opioid agonists in mice.
    Goicoechea C; Ormazábal MJ; Alfaro MJ; Martín MI
    Neurosci Lett; 1999 Feb; 262(1):25-8. PubMed ID: 10076864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
    Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
    Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors.
    Valverde O; Ledent C; Beslot F; Parmentier M; Roques BP
    Eur J Neurosci; 2000 Feb; 12(2):533-9. PubMed ID: 10712632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripherally acting opioid analgesics and peripherally-induced analgesia.
    Martínez V; Abalo R
    Behav Pharmacol; 2020 Apr; 31(2&3):136-158. PubMed ID: 32168025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.